Washington SB 5251: Concerning prescription drug cost transparency.

Status: By resolution, reintroduced and retained in present status. (as of 2020-01-13)

State: Washington · Session: 2019-2020 · Bill: SB 5251

Subjects: FINANCIAL MANAGEMENT, OFFICE, PUBLIC FUNDS AND ACCOUNTS, HEALTH CARE AUTHORITY, INSURANCE, DRUGS

Sponsors: Mullet, Palumbo, Rivers, Rolfes

View Washington SB 5251 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.